HQ Function

The Waltham headquarters served as the main hub for Histogenics' corporate administration, research and development activities, and clinical trial operations management.

Notable Features:

The facility was likely standard for a biotech company of its size, comprising office spaces and potentially some laboratory facilities, situated within a modern office park.

Work Culture:

As a clinical-stage biopharmaceutical company, the work culture at Histogenics likely emphasized scientific innovation, rigorous research, and a strong focus on achieving clinical milestones. It would have been a dynamic environment, particularly during its active clinical trial phases.

HQ Significance:

This headquarters was the nerve center for the development of NeoCart® and represented the company's strategic presence in a key U.S. biotech cluster, facilitating access to talent and resources.

Values Reflected in HQ: The choice of location in a major biotech hub reflected a commitment to innovation, scientific excellence, and collaboration within the life sciences industry.

Location:

Histogenics' core operations, including research, clinical development, and manufacturing, were primarily concentrated in the United States. While its main focus was the U.S. market, Histogenics did engage in some international activities, such as a partnership with MEDINET Co., Ltd. for the potential development and commercialization of NeoCart® in Japan. However, its direct operational footprint remained largely U.S.-based prior to its merger.

Street Address:

830 Winter Street, Suite 300

City:

Waltham

State/Province:

MA

Country:

USA